Tristel is a manufacturer of infection control, contamination control and hygiene products. It has four principal activities:
-Medical Instrument Disinfection under the Tristel brand
-Hospital Surface Disinfection under the Cache brand
-Cleanroom, pharma and lab under the Crystel brand
-Infection prevention in animal healthcare under the Anistel brand
The Tristel story began in 1993 when the founding shareholders developed a proprietary chlorine dioxide formulation to be used for the disinfection of flexible endoscopes to replace glutaraldehyde. Glutaraldehyde was at the time used universally throughout all hospitals in the United Kingdom, and indeed worldwide, for the disinfection of heat-sensitive medical instruments. However, it was known to be toxic.
During the course of the following decade Tristel gradually captured significant market share in the United Kingdom hospital market. In June 2005 Tristel plc was listed on the London Stock Exchange AIM market.